Inventor · disambiguated record
Herbert Y. Lin
Also filed as: LIN HERBERT · LIN HERBERT Y
22 granted patents·11 pending applications·344 citations·filing 1994–2021
96Inventor score
Files withLIN HERBERT Y8MASSACHUSETTS GEN HOSPITAL6WHITEHEAD BIOMEDICAL INST6NAKAYAMA TOMOKO4ALNYLAM PHARMACEUTICALS INC3
Top patents by PatentIndex Score
33 records- 0196US8865168B2Methods and compositions to regulate hepcidin expressionGEN HOSPITAL CORP·Filed 2012·Granted Oct 21, 2014·34 cites·29 claims
- 0296US8637023B2Hemojuvelin fusion proteinsLIN HERBERT Y·Filed 2012·Granted Jan 28, 2014·39 cites·18 claims
- 0396US7968091B2Methods and compositions to regulate iron metabolismGEN HOSPITAL CORP·Filed 2006·Granted Jun 28, 2011·50 cites·6 claims
- 0495US8293236B2Use of modulators of compounds of TGF-β superfamily to regulate hepcidin-mediated iron metabolismLIN HERBERT Y·Filed 2011·Granted Oct 23, 2012·31 cites·12 claims
- 0593US8470799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2012·Granted Jun 25, 2013·9 cites·20 claims
- 0693US8268799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2011·Granted Sep 18, 2012·10 cites·24 claims
- 0792US8791250B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 29, 2014·7 cites·20 claims
- 0887US9556251B2Methods and compositions to regulate hepcidin expressionMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Jan 31, 2017·6 cites·19 claims
- 0987US8895002B2Hemojuvelin fusion proteins and uses thereofLIN HERBERT Y·Filed 2008·Granted Nov 25, 2014·8 cites·38 claims
- 1085US8163711B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2010·Granted Apr 24, 2012·5 cites·19 claims
- 1183US6001969ARecombinant TGF-β type II receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Dec 14, 1999·40 cites·18 claims
- 1281US9090895B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·1 cites·20 claims
- 1381US6008011ATGF-β type II receptor cDNAsWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Dec 28, 1999·34 cites·24 claims
- 1480US9708379B2Compositions for regulating iron homeostasis and methods of using sameLIN HERBERT Y·Filed 2012·Granted Jul 18, 2017·7 cites·39 claims
- 1580US6010872ARecombinant production of TGF-β type III receptor (betaglycan) polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1994·Granted Jan 4, 2000·25 cites·40 claims
- 1673US10273273B2Compositions for regulating iron homeostasis and methods of using sameFERRUMAX PHARMACEUTICALS INC·Filed 2017·Granted Apr 30, 2019·3 cites·19 claims
- 1766US6201108B1TGF-β type receptor cDNAs encoded products and uses thereforWHITEHEAD INST FOR MEDICAL RES·Filed 1995·Granted Mar 13, 2001·15 cites·6 claims
- 1865US9506067B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·0 cites·20 claims
- 1964US10611820B2Nucleic acids encoding hemojuvelin fusion proteins and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Apr 7, 2020·0 cites·20 claims
- 2064US6046157AModulation of TGF-β by recombinant TGF-β type II receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1995·Granted Apr 4, 2000·12 cites·21 claims
- 2164US2009209478A1Compositions and methods for inhibiting expression of the hamp geneNAKAYAMA TOMOKO·Filed 2007·Application pending·0 cites
- 2263US9758567B2Hemojuvelin fusion proteins and uses thereofMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Sep 12, 2017·0 cites·21 claims
- 2363US2008234216A1TGF-beta type receptor cDNAs encoded products and uses thereforLIN HERBERT Y·Filed 2007·Application pending·0 cites
- 2460US2017183411A1Methods and compositions to regulate hepcidin expressionMASSACHUSETTS GEN HOSPITAL·Filed 2016·Application pending·0 cites
- 2560US2006247198A1TGF-beta type receptor cDNAs encoded products and uses thereforLIN HERBERT Y·Filed 2006·Application pending·0 cites
- 2659US2014199314A1Methods and compositions for regulating iron homeostasis by modulation of bmp-6GEN HOSPITAL CORP·Filed 2013·Application pending·0 cites
- 2758US6086867AModulation of TGF-β by TGF-β type III receptor polypeptidesWHITEHEAD BIOMEDICAL INST·Filed 1998·Granted Jul 11, 2000·8 cites·20 claims
- 2856US2005260579A1TGF-beta type receptor cDNAs encoded productsWHITEHEAD BIOMEDICAL INST·Filed 2003·Application pending·0 cites
- 2954US2021388069A1Methods and compositions for regulating iron homeostasis by modulation of bmp-6MASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 3053US2007184052A1Soluble tgf-b type III receptor fusion proteinsLIN HERBERT Y·Filed 2004·Application pending·0 cites
- 3152US2014086919A1Methods and compositons for regulating iron homeostasis by modulation of bmp-6LIN HERBERT Y·Filed 2012·Application pending·0 cites
- 3251US2017362311A1Methods and compositions for regulating iron homeostasis by modulation of bmp-6MASSACHUSETTS GEN HOSPITAL·Filed 2017·Application pending·0 cites
- 3345US2020383574A1Methods of fluid assessment and treatmentMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Herbert Y. Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →